DNA

Ginkgo Bioworks Holdings Inc

Mar 18 • 02:54PM ET

6.68

-0.15 -2.20 %

Healthcare • Biotechnology • USA • NYSE

Peers: REGN SGMO EDIT CRSP NTLA TWST DNLI BEAM FATE CERS

| Held by: VTI IWM VXF KOMP THNQ IWN IBB PRFZ SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-5.68	Insider Own	24.90%	Shs Outstand	46.79M	Perf Week	-2.20%
Market Cap	409.88M	Forward P/E	-	EPS next Y	-3.86	Insider Trans	-0.06%	Shs Float	43.82M	Perf Month	-25.78%
Enterprise Value	420.11M	PEG	-	EPS next Q	-1.21	Inst Own	58.26%	Short Float	17.08%	Perf Quarter	-22.95%
Income	-312.76M	P/S	2.41	EPS this Y	21.53%	Inst Trans	5.62%	Short Ratio	6.75	Perf Half Y	-37.16%
Sales	170.16M	P/B	0.73	EPS next Y	12.78%	ROA	-25.05%	Short Interest	7.49M	Perf YTD	-19.61%
Book/sh	9.21	P/C	0.95	EPS next 5Y	-	ROE	-51.08%	52W High	17.58 -62.00%	Perf Year	-8.24%
Cash/sh	7.00	P/FCF	-	EPS past 3/5Y	51.73% -7.49%	ROIC	-33.79%	52W Low	5.00 33.60%	Perf 3Y	-86.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-29.11% 17.29%	Gross Margin	40.49%	Volatility	7.18% 7.93%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.47	EPS Y/Y TTM	46.46%	Oper. Margin	-184.60%	ATR (14)	0.63	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.92	Sales Y/Y TTM	-25.06%	Profit Margin	-183.81%	RSI (14)	40.27	Recom	3.67
Dividend Gr. 3/5Y	- -	Current Ratio	4.92	EPS Q/Q	27.13%	SMA20	-10.63%	Beta	1.56	Target Price	8.50
Payout	-	Debt/Eq	0.86	Sales Q/Q	-23.84%	SMA50	-22.49%	Rel Volume	0.37	Prev Close	6.83
Employees	485	LT Debt/Eq	0.82	Earnings	Feb 26 AMC	SMA200	-35.68%	Avg Volume	1.11M	Price	6.68
IPO	Apr 19, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.09% -11.03%	Trades		Volume	347,448	Change	-2.20%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform	$3.50 → $2.50
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell	$3 → $1.25
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy	$6
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight	$5
May-18-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Mar-02-22	Resumed	Cowen	Outperform	$12
Feb-23-22	Initiated	Goldman	Neutral	$7
Feb-01-22	Initiated	BofA Securities	Neutral	$6
Jan-28-22	Initiated	BofA Securities	Buy	$8
Jan-07-22	Initiated	BTIG Research	Buy	$12
Nov-29-21	Initiated	Jefferies	Buy	$16
Oct-13-21	Initiated	Raymond James	Outperform	$14.50
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy	$14

Show Previous Ratings

Mar-07-26 03:01PM	Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen (Benzinga)
Mar-02-26 08:00AM	Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure (PR Newswire)
Feb-28-26 12:07AM	Ginkgo Bioworks Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 08:02PM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... (GuruFocus.com) -30.48%
11:50AM	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter (Benzinga)
08:30AM	Loading…
08:30AM	Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
Feb-26-26 04:26PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business (PR Newswire)
Feb-25-26 07:35AM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.87%
Feb-19-26 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation (PR Newswire) +8.27%
Feb-18-26 08:00AM	Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products (PR Newswire)
Feb-17-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Feb-10-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks) -9.06%
Feb-06-26 06:26AM	Ginkgo, OpenAI Cut Protein Costs by 40% (GuruFocus.com) +21.39%
Feb-05-26 02:00PM	Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark (PR Newswire)
Feb-04-26 06:15PM	Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today (Zacks) -5.92%
06:15PM	Loading…
Jan-29-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors (Zacks)
Jan-23-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -6.36%
Jan-14-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-13-26 08:00AM	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks) -5.72%
Dec-31-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts (Zacks)
Dec-22-25 01:21PM	Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach (PR Newswire) +8.52%
Dec-17-25 08:00AM	Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment (PR Newswire)
Dec-09-25 08:00AM	Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety (PR Newswire)
Dec-05-25 08:33AM	Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PC (PR Newswire)
Dec-03-25 08:00AM	STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy (PR Newswire)
Nov-18-25 08:00AM	Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health (PR Newswire)
Nov-07-25 04:00AM	Ginkgo Bioworks Holdings Inc (DNA) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... (GuruFocus.com) -20.80%
Nov-06-25 04:05PM	Ginkgo Bioworks Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-05-25 07:46AM	Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2025 Result (GuruFocus.com)
08:00AM	Loading…
Nov-03-25 08:00AM	Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium (PR Newswire)
Oct-31-25 08:00AM	Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture (PR Newswire) +8.16%
Oct-30-25 04:05PM	Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation (PR Newswire)
Oct-28-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Oct-23-25 08:00AM	Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program (PR Newswire)
Oct-22-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Oct-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know (Zacks) -12.37%
Oct-09-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.28% -11.29%
Oct-03-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know (Zacks) -7.87%
Sep-30-25 12:39PM	Ginkgo Bioworks Holdings Stock Scores RS Rating Upgrade (Investor's Business Daily) +10.20%
Sep-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Advances While Market Declines: Some Information for Investors (Zacks) -6.64%
Sep-04-25 08:00AM	Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium (Business Wire)
Aug-29-25 04:05PM	Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions (PR Newswire) -13.02%
Aug-20-25 08:01AM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry (PR Newswire)
Aug-13-25 09:30AM	Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average (Zacks) +14.71%
Aug-12-25 08:01AM	Ginkgo Automation Appoints Brian?O'Sullivan as Head of Commercial to Accelerate External Growth (PR Newswire)
Aug-08-25 03:46AM	Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... (GuruFocus.com) -8.69%
Aug-07-25 05:01PM	Ginkgo Bioworks Reports Second Quarter 2025 Financial Results (PR Newswire)
Jul-31-25 09:30AM	Ginkgo Bioworks awarded $4.66M contract by PNNL (TipRanks)
08:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation (PR Newswire)
Jul-30-25 09:01AM	Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy (PR Newswire)
Jul-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.31%
Jul-17-25 09:01AM	Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire)
Jul-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-10-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why (Zacks) -7.51%
Jul-01-25 06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know (Zacks)
May-21-25 04:05PM	Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer (PR Newswire) -7.38% -7.43%
May-08-25 11:36PM	Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.35%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.79% +14.73%
05:00PM	Ginkgo Bioworks Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 07:50AM	Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.56%
Apr-30-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:00AM	Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors (PR Newswire)
Apr-29-25 04:00PM	Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation (PR Newswire) -7.98%
Apr-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Apr-22-25 09:00AM	Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
09:00AM	Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
Apr-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know (Zacks)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +11.23%
Apr-10-25 09:55AM	Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet (Zacks) +7.67%
09:00AM	Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain (PR Newswire)
Apr-01-25 10:26AM	Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
09:35AM	Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks (Zacks)
Mar-27-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) -7.13%
Mar-21-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +5.91%
Mar-14-25 09:35AM	After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) +7.89%
Mar-05-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why (Zacks)
Feb-25-25 05:00PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -11.47%
Feb-21-25 09:00AM	Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab (PR Newswire) -5.34%
Feb-20-25 08:01AM	Ginkgo Bioworks Partners with HaDEA in Up to 24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care (PR Newswire) -9.86%
Feb-18-25 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation (PR Newswire) -6.52%
Feb-06-25 08:01AM	Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series (PR Newswire) -16.38%
Jan-29-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jan-23-25 08:01AM	Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) (PR Newswire)
Jan-13-25 08:01AM	Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors (PR Newswire) -9.41%
Jan-09-25 11:38AM	Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics (GlobeNewswire)
08:00AM	Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-17-24 12:00PM	All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy (Zacks)
08:11AM	Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program (PR Newswire)
Nov-12-24 05:01PM	Ginkgo Bioworks Reports Third Quarter 2024 Financial Results (PR Newswire)
08:01AM	Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing (PR Newswire)
Nov-05-24 07:00AM	Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation (PR Newswire)
Sep-24-24 07:01AM	NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture (PR Newswire)
Sep-18-24 07:01AM	Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology (PR Newswire) +8.81%
Sep-17-24 08:01AM	Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology (PR Newswire) +9.31%
Sep-04-24 04:30PM	Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement (PR Newswire)
Aug-30-24 07:00AM	Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) -5.64%
Aug-19-24 07:56AM	Upcoming Stock Splits This Week (August 19 to August 23) Stay Invested (TipRanks) +5.64%

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coen Steven P.	Officer	Mar 16 '26	Proposed Sale	6.74	708	4,769		Mar 16 04:13 PM
Che Austin	Officer	Mar 11 '26	Proposed Sale	6.31	2,200	13,882		Mar 11 10:14 AM
Che Austin	Officer	Feb 04 '26	Proposed Sale	8.80	2,200	19,360		Feb 04 09:52 AM
Coen Steven P.	See remarks	Jan 20 '26	Sale	8.92	972	8,667	8,321	Jan 22 04:12 PM
Coen Steven P.	Officer	Jan 20 '26	Proposed Sale	8.92	972	8,667		Jan 20 04:15 PM
Che Austin	Officer	Jan 07 '26	Proposed Sale	9.16	2,200	20,152		Jan 07 10:09 AM
Coen Steven P.	See remarks	Dec 15 '25	Sale	8.89	736	6,540	7,488	Dec 16 05:11 PM
Coen Steven P.	Officer	Dec 15 '25	Proposed Sale	8.89	736	6,540		Dec 15 04:20 PM
Che Austin	Officer	Dec 10 '25	Proposed Sale	9.54	2,200	20,988		Dec 10 11:09 AM
Che Austin	Officer	Nov 12 '25	Proposed Sale	8.50	2,200	18,700		Nov 12 10:06 AM
Coen Steven P.	See remarks	Oct 17 '25	Sale	13.65	1,312	17,907	6,738	Oct 21 04:56 PM
Coen Steven P.	Officer	Oct 21 '25	Proposed Sale	15.00	5,609	84,135		Oct 21 02:53 PM
Coen Steven P.	Officer	Oct 21 '25	Proposed Sale	13.65	1,312	17,908		Oct 21 01:59 PM
Che Austin	Officer	Oct 08 '25	Proposed Sale	15.21	2,200	33,462		Oct 08 09:43 AM
Coen Steven P.	See remarks	Oct 01 '25	Sale	15.00	5,609	84,135	5,503	Oct 03 05:01 PM
HENRY CHRISTIAN O	Director	Sep 09 '25	Sale	11.06	10,000	110,600	24,310	Sep 10 04:06 PM
HENRY CHRISTIAN O	Director	Sep 08 '25	Sale	10.92	10,000	109,200	34,310	Sep 10 04:06 PM
Che Austin	Officer	Sep 10 '25	Proposed Sale	10.78	2,200	23,716		Sep 10 09:51 AM
HENRY CHRISTIAN O	Director	Sep 09 '25	Proposed Sale	11.06	10,000	110,600		Sep 09 11:06 AM
HENRY CHRISTIAN O	Director	Sep 08 '25	Proposed Sale	10.92	10,000	109,209		Sep 08 12:19 PM
Coen Steven P.	See remarks	Aug 22 '25	Sale	12.40	310	3,843	11,112	Aug 26 04:10 PM
Che Austin	Officer	Aug 06 '25	Proposed Sale	14.10	2,200	31,020		Aug 06 09:48 AM
Coen Steven P.	See remarks	Jul 17 '25	Sale	9.84	1,084	10,669	10,679	Jul 21 04:28 PM
Dmytruk Mark E.	Officer	Jul 17 '25	Proposed Sale	9.84	640	6,299		Jul 17 05:20 PM
Che Austin	Officer	Jul 09 '25	Proposed Sale	11.18	2,200	24,596		Jul 09 12:07 PM
Che Austin	Officer	Jun 23 '25	Proposed Sale	8.43	99	835		Jun 23 09:54 AM
Che Austin	Officer	Jun 20 '25	Proposed Sale	8.66	99	857		Jun 20 09:50 AM
Che Austin	Officer	Jun 18 '25	Proposed Sale	8.46	99	838		Jun 18 09:41 AM
Che Austin	Officer	Jun 17 '25	Proposed Sale	9.06	99	897		Jun 17 11:58 AM
Che Austin	Officer	Jun 16 '25	Proposed Sale	9.04	99	895		Jun 16 10:21 AM
Che Austin	Officer	Jun 13 '25	Proposed Sale	8.92	99	883		Jun 13 10:04 AM
Che Austin	Officer	Jun 12 '25	Proposed Sale	9.51	99	941		Jun 12 09:45 AM
Che Austin	Officer	Jun 11 '25	Proposed Sale	8.93	99	884		Jun 11 09:58 AM
Che Austin	Officer	Jun 10 '25	Proposed Sale	7.99	99	791		Jun 10 10:07 AM
Che Austin	Officer	Jun 09 '25	Proposed Sale	7.75	99	767		Jun 09 10:01 AM
Che Austin	Officer	Jun 06 '25	Proposed Sale	7.32	99	725		Jun 06 10:05 AM
Che Austin	Officer	Jun 05 '25	Proposed Sale	7.60	99	752		Jun 05 10:20 AM
Che Austin	Officer	Jun 04 '25	Proposed Sale	7.55	99	747		Jun 04 10:26 AM
Che Austin	Officer	Jun 03 '25	Proposed Sale	7.27	99	720		Jun 03 10:08 AM
Che Austin	Officer	Jun 02 '25	Proposed Sale	6.97	99	690		Jun 02 09:47 AM
Che Austin	Officer	May 30 '25	Proposed Sale	7.12	99	705		May 30 09:40 AM
Che Austin	Officer	May 29 '25	Proposed Sale	7.62	99	754		May 29 09:37 AM
Che Austin	Officer	May 28 '25	Proposed Sale	6.96	99	689		May 28 09:36 AM
Che Austin	Officer	May 27 '25	Proposed Sale	7.20	99	713		May 27 11:00 AM
Che Austin	Officer	May 23 '25	Proposed Sale	6.75	99	668		May 23 09:55 AM
Coen Steven P.	See remarks	May 21 '25	Sale	7.58	346	2,624	9,216	May 22 04:06 PM
Dmytruk Mark E.	See remarks	May 21 '25	Sale	7.58	706	5,355	46,226	May 22 04:05 PM
Che Austin	Officer	May 22 '25	Proposed Sale	7.15	99	708		May 22 09:54 AM
Dmytruk Mark E.	Officer	May 21 '25	Proposed Sale	7.58	706	5,355		May 21 04:11 PM
Che Austin	Officer	May 21 '25	Proposed Sale	7.86	99	778		May 21 09:54 AM
Che Austin	Officer	May 20 '25	Proposed Sale	8.10	99	802		May 20 09:41 AM
Che Austin	Officer	May 19 '25	Proposed Sale	7.70	99	762		May 19 11:03 AM
Che Austin	Officer	May 16 '25	Proposed Sale	7.72	99	764		May 16 09:40 AM
Che Austin	Officer	May 15 '25	Proposed Sale	7.73	99	765		May 15 10:57 AM
Che Austin	Officer	May 14 '25	Proposed Sale	8.01	99	793		May 14 10:18 AM
Che Austin	Officer	May 13 '25	Proposed Sale	8.40	99	832		May 13 09:48 AM
Che Austin	Officer	May 12 '25	Proposed Sale	8.16	99	808		May 12 09:44 AM
Che Austin	Officer	May 09 '25	Proposed Sale	7.97	99	789		May 09 09:40 AM
Che Austin	Officer	May 08 '25	Proposed Sale	7.49	99	742		May 08 09:46 AM
Che Austin	Officer	May 07 '25	Proposed Sale	6.83	99	676		May 07 09:52 AM
Che Austin	Officer	May 06 '25	Proposed Sale	6.75	99	668		May 06 09:41 AM
Che Austin	Officer	May 05 '25	Proposed Sale	7.00	99	693		May 05 09:58 AM
Che Austin	Officer	May 02 '25	Proposed Sale	7.15	99	708		May 02 09:41 AM
Che Austin	Officer	May 01 '25	Proposed Sale	7.47	99	740		May 01 10:07 AM
Che Austin	Officer	Apr 30 '25	Proposed Sale	7.14	99	707		Apr 30 09:59 AM
Che Austin	Officer	Apr 29 '25	Proposed Sale	7.94	99	786		Apr 29 09:51 AM
Che Austin	Officer	Apr 28 '25	Proposed Sale	7.95	99	787		Apr 28 09:50 AM
Che Austin	Officer	Apr 25 '25	Proposed Sale	7.92	99	784		Apr 25 09:49 AM
Che Austin	Officer	Apr 24 '25	Proposed Sale	7.68	99	760		Apr 24 09:47 AM
Coen Steven P.	See remarks	Apr 21 '25	Sale	7.28	997	7,261	8,819	Apr 23 05:03 PM
Dmytruk Mark E.	See remarks	Apr 21 '25	Sale	7.28	1,244	9,060	45,453	Apr 23 05:00 PM
Che Austin	Officer	Apr 23 '25	Proposed Sale	8.05	99	797		Apr 23 09:54 AM
Che Austin	Officer	Apr 22 '25	Proposed Sale	7.49	99	742		Apr 22 09:48 AM
Dmytruk Mark E.	Officer	Apr 21 '25	Proposed Sale	7.28	1,244	9,060		Apr 21 04:16 PM
Che Austin	Officer	Apr 21 '25	Proposed Sale	7.50	99	742		Apr 21 09:51 AM
Che Austin	Officer	Apr 17 '25	Proposed Sale	8.09	99	801		Apr 17 09:49 AM
Che Austin	Officer	Apr 16 '25	Proposed Sale	8.17	99	809		Apr 16 09:49 AM
Che Austin	Officer	Apr 15 '25	Proposed Sale	8.41	99	833		Apr 15 09:47 AM
Che Austin	Officer	Apr 14 '25	Proposed Sale	8.37	99	829		Apr 14 10:10 AM
Che Austin	Officer	Apr 11 '25	Proposed Sale	7.50	99	742		Apr 11 09:42 AM
Che Austin	Officer	Apr 10 '25	Proposed Sale	6.54	99	647		Apr 10 09:45 AM
Che Austin	Officer	Apr 09 '25	Proposed Sale	5.73	99	567		Apr 09 09:47 AM
Che Austin	Officer	Apr 08 '25	Proposed Sale	6.80	99	673		Apr 08 09:38 AM
Che Austin	Officer	Apr 07 '25	Proposed Sale	5.16	99	511		Apr 07 10:36 AM
Che Austin	Officer	Apr 04 '25	Proposed Sale	5.50	99	544		Apr 04 09:40 AM
Che Austin	Officer	Apr 03 '25	Proposed Sale	5.50	99	544		Apr 03 10:17 AM
Che Austin	Officer	Apr 02 '25	Proposed Sale	5.45	99	540		Apr 02 10:10 AM
Che Austin	Officer	Apr 01 '25	Proposed Sale	5.69	99	563		Apr 01 10:57 AM
Che Austin	Officer	Mar 31 '25	Proposed Sale	5.73	99	567		Mar 31 09:58 AM
Che Austin	Officer	Mar 28 '25	Proposed Sale	6.54	99	647		Mar 28 10:57 AM
Che Austin	Officer	Mar 27 '25	Proposed Sale	6.63	99	656		Mar 27 09:36 AM
Che Austin	Officer	Mar 26 '25	Proposed Sale	7.11	99	704		Mar 26 09:49 AM
Che Austin	Officer	Mar 25 '25	Proposed Sale	7.75	99	767		Mar 25 09:51 AM
Che Austin	Officer	Mar 24 '25	Proposed Sale	7.53	99	745		Mar 24 09:53 AM
Che Austin	Officer	Mar 21 '25	Proposed Sale	7.00	99	693		Mar 21 09:44 AM
Che Austin	Officer	Mar 20 '25	Proposed Sale	7.40	99	733		Mar 20 09:42 AM
Che Austin	Officer	Mar 19 '25	Proposed Sale	7.27	99	720		Mar 19 09:42 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DNA

Ginkgo Bioworks Holdings Inc

Upgrade your FINVIZ experience